Skip to main content
EJNMMI Physics

Table 3 Statistical comparison for 21 pre-treatment (simulation) dosimetries regarding tumor dose, non-tumoral liver (NTL) dose, tumor fraction receiving at least 150 Gy, and non-tumoral liver (NTL) fraction receiving between 0 and 50 Gy

From: Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using 166Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imaging

Criteria

DEW [mean ± std dev]

TEW [mean ± std dev]

p-val

Tumor dose

201.86 ± 49.73 Gy

229.43 ± 44.30 Gy

0.01*

NTL dose

40.00 ± 22.34 Gy

36.90 ± 23.47 Gy

0.02*

 ≥ 150 Gy tumor fraction

72.57 ± 23.55%

81.17 ± 17.17%

0.03*

0–50 Gy NTL fraction

71.30 ± 16.27%

75.60 ± 16.21%

0.01*

  1. p-values (p-val) are obtained from paired t-test analysis and considered significant if ≤ 0.05 (*)
Back to article page